InsiderClue
Insiders · Profile

Mahony Susan

Director at Axsome Therapeutics · SVP & Pres., Lilly Oncology at Lilly (Eli). Filing since 24 Oct 2012. CIK 0001463321

AXSM Axsome Therapeutics, Inc. Director · 2 trades LLY Lilly (Eli) SVP & Pres., Lilly Oncology · 12 trades
Company
Date
Role
Action
Shares
Amount
Of holding
AXSM Axsome Therapeutics, Inc.
10 Jun 2026
Director
Sold on a plan
300
$73.85K
26.6%
AXSM Axsome Therapeutics, Inc.
9 Jun 2026
Director
Sold on a plan
300
$71.16K
21.0%
LLY Lilly (Eli)
16 Apr 2018
SVP & Pres., Lilly Oncology
Sold, plan not stated
17,379
$1.39M
38.1%
LLY Lilly (Eli)
13 Apr 2018
SVP & Pres., Lilly Oncology
Sold, plan not stated
5,165
$413.92K
10.2%
LLY Lilly (Eli)
4 Dec 2017
SVP & Pres., Lilly Oncology
Sold, plan not stated
36,585
$3.15M
40.0%
LLY Lilly (Eli)
16 Dec 2016
SVP & Pres., Lilly Oncology
Sold, plan not stated
19,093
$1.39M
22.0%
LLY Lilly (Eli)
16 Dec 2016
SVP & Pres., Lilly Oncology
Sold, plan not stated
1,149
$83.51K
9.1%
LLY Lilly (Eli)
28 Jul 2015
SVP & Pres., Lilly Oncology
Sold, plan not stated
25,000
$2.12M
28.5%
LLY Lilly (Eli)
28 Jul 2014
SVP & Pres., Lilly Oncology
Sold, plan not stated
2,065
$130.71K
20.9%
LLY Lilly (Eli)
25 Jul 2014
SVP & Pres., Lilly Oncology
Sold, plan not stated
30,000
$1.92M
36.2%
LLY Lilly (Eli)
29 Apr 2013
SVP & Pres., Lilly Oncology
Sold, plan not stated
3,500
$197.16K
7.4%
LLY Lilly (Eli)
26 Mar 2013
SVP & Pres., Lilly Oncology
Sold, plan not stated
5,000
$280.00K
9.5%
LLY Lilly (Eli)
1 Feb 2013
SVP & Pres., Lilly Oncology
Sold, plan not stated
5,000
$271.40K
8.7%
LLY Lilly (Eli)
24 Oct 2012
SVP & Pres., Lilly Oncology
Sold, plan not stated
10,000
$504.50K
32.7%
14 decisions on file.